GENN logo

Genesis Healthcare, Inc. (GENN) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

GENN representa a Genesis Healthcare, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 46/100

Genesis Healthcare, Inc. (GENN) Resumen de Asistencia Médica y Tuberías

CEODavid Sheridan Harrington
Empleados44000
Sede CentralKennett Square, US
Año de la oferta pública inicial (OPI)2007

Genesis Healthcare, Inc. provides skilled nursing and rehabilitation services across the United States, operating a network of facilities and offering specialized medical services. Facing competitive pressures and regulatory changes, the company focuses on delivering inpatient and rehabilitation services to a diverse patient base.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Genesis Healthcare operates in a challenging environment, reflected in its negative profit margin of -1.5%. The company's gross margin stands at 42.2%. Key value drivers include its extensive network of facilities and the demand for skilled nursing and rehabilitation services. Growth catalysts involve expanding rehabilitation services and optimizing facility operations. Potential risks include regulatory changes, reimbursement pressures, and competition from other healthcare providers. Investors should monitor the company's ability to improve profitability and navigate the evolving healthcare landscape. The company's beta of -1.21 suggests a negative correlation to market movements.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Operates approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020.
  • Provides rehabilitation therapy services to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China.
  • Profit margin of -1.5% indicates ongoing challenges in achieving profitability.
  • Gross margin of 42.2% reflects the company's ability to manage direct costs effectively.
  • Employs approximately 44,000 individuals, highlighting its significant role as an employer in the healthcare sector.

Competidores y Pares

Fortalezas

  • Extensive network of facilities.
  • Comprehensive range of services.
  • Established presence in multiple states.
  • Experienced management team.

Debilidades

  • Negative profit margin.
  • High debt levels.
  • Exposure to regulatory changes.
  • Dependence on government reimbursement programs.

Catalizadores

  • Ongoing: Expansion of rehabilitation services to new geographic markets and healthcare settings.
  • Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
  • Ongoing: Technology integration and innovation to improve operational efficiency and patient care.
  • Ongoing: Focus on value-based care models to improve patient outcomes and reduce costs.
  • Ongoing: Development of specialty programs to cater to specific patient populations and healthcare needs.

Riesgos

  • Potential: Increasing competition from other healthcare providers.
  • Potential: Rising labor costs and staffing shortages.
  • Potential: Changes in government reimbursement policies.
  • Potential: Economic downturns and reduced consumer spending.
  • Ongoing: Regulatory changes and compliance requirements.

Oportunidades de crecimiento

  • Expansion of Rehabilitation Services: Genesis Healthcare can expand its rehabilitation therapy services to new geographic markets and healthcare settings. The market for rehabilitation services is projected to grow as the population ages and the demand for post-acute care increases. By leveraging its existing infrastructure and expertise, Genesis Healthcare can capture a larger share of this market, potentially increasing revenue by 10-15% over the next three years.
  • Strategic Partnerships and Acquisitions: Genesis Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Collaborating with hospitals, physician groups, and other healthcare providers can enhance patient referrals and improve care coordination. Acquiring smaller skilled nursing facilities and assisted living communities can provide access to new markets and patient populations, driving revenue growth and market share gains.
  • Technology Integration and Innovation: Investing in technology and innovation can improve operational efficiency, enhance patient care, and reduce costs. Implementing electronic health records (EHRs), telehealth solutions, and remote monitoring devices can streamline workflows, improve communication, and enable more personalized care. These technologies can also help Genesis Healthcare attract and retain patients, improve patient satisfaction, and reduce hospital readmission rates.
  • Focus on Value-Based Care: Shifting towards value-based care models can improve patient outcomes, reduce costs, and enhance reimbursement rates. By participating in accountable care organizations (ACOs) and other value-based payment arrangements, Genesis Healthcare can align its incentives with those of payers and providers. This can lead to increased patient referrals, improved care coordination, and higher reimbursement rates, driving revenue growth and profitability.
  • Development of Specialty Programs: Genesis Healthcare can develop specialty programs to cater to specific patient populations and healthcare needs. Examples include programs for patients with Alzheimer's disease, Parkinson's disease, and other chronic conditions. By offering specialized care and services, Genesis Healthcare can attract patients with complex medical needs and differentiate itself from competitors. This can lead to increased patient referrals, higher reimbursement rates, and improved patient outcomes.

Oportunidades

  • Expansion of rehabilitation services.
  • Strategic partnerships and acquisitions.
  • Technology integration and innovation.
  • Focus on value-based care.

Amenazas

  • Increasing competition.
  • Rising labor costs.
  • Changes in reimbursement policies.
  • Economic downturns.

Ventajas competitivas

  • Extensive network of skilled nursing and assisted living facilities.
  • Established relationships with healthcare providers and payers.
  • Comprehensive range of rehabilitation therapy services.
  • Experience in providing care to diverse patient populations.

Acerca de GENN

Genesis Healthcare, Inc., founded in 2003 and headquartered in Kennett Square, Pennsylvania, is a major provider of skilled nursing and assisted living services in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Its Inpatient Services segment includes a network of approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020. The Rehabilitation Therapy Services segment offers physical therapy, occupational therapy, speech-language pathology, and respiratory therapy. These services are provided to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China. The Other Services segment provides physician, staffing, and other healthcare-related services. Genesis Healthcare was formerly known as FC-GEN Operations Investment, LLC, changing its name in February 2015. The company's focus is on providing comprehensive care and rehabilitation services to patients requiring skilled nursing and assisted living support.

Qué hacen

  • Owns and operates skilled nursing facilities.
  • Operates assisted/senior living facilities.
  • Provides inpatient services.
  • Offers rehabilitation therapy services (physical, occupational, speech).
  • Supplies respiratory therapy services.
  • Offers physician staffing services.
  • Provides other healthcare-related services.

Modelo de Negocio

  • Generates revenue from inpatient services provided at skilled nursing and assisted living facilities.
  • Earns revenue from rehabilitation therapy services offered to patients in various healthcare settings.
  • Receives payments from Medicare, Medicaid, and private insurance companies.
  • Provides staffing and other healthcare-related services to generate additional revenue.

Contexto de la Industria

Genesis Healthcare operates within the medical care facilities industry, which is influenced by factors such as an aging population, increasing demand for long-term care services, and evolving regulatory requirements. The industry is competitive, with key players including ACORQ, CHCR, GDBYF, GNBT, and MGFRF. Market trends include a growing emphasis on value-based care, the integration of technology to improve patient outcomes, and the expansion of home-based care services. Genesis Healthcare's position is defined by its extensive network of facilities and its focus on providing comprehensive rehabilitation and skilled nursing services.

Clientes Clave

  • Individuals requiring skilled nursing care.
  • Seniors needing assisted living services.
  • Patients requiring rehabilitation therapy.
  • Hospitals and healthcare facilities needing rehabilitation and respiratory therapy services.
Confianza de la IA: 69% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Genesis Healthcare, Inc. (GENN): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para GENN.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para GENN.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para GENN.

MoonshotScore

46/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de GENN en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: David Sheridan Harrington

CEO

David Sheridan Harrington serves as the CEO of Genesis Healthcare, overseeing the operations of a large healthcare organization with approximately 44,000 employees. His background includes extensive experience in healthcare management and leadership. He is responsible for setting the strategic direction of the company, managing its financial performance, and ensuring the delivery of high-quality care to patients. Harrington's leadership is focused on driving innovation, improving operational efficiency, and enhancing patient outcomes.

Historial: Under David Sheridan Harrington's leadership, Genesis Healthcare has focused on navigating the challenges of the healthcare industry, including regulatory changes and reimbursement pressures. Key milestones include efforts to expand rehabilitation services and improve facility operations. His strategic decisions aim to enhance the company's financial performance and ensure the long-term sustainability of its business model.

Información del mercado OTC de GENN

The OTC Other tier represents the lowest tier of the OTC market, indicating that Genesis Healthcare may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier typically involves higher risks compared to exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity on the OTC market can be highly variable, and it is essential to assess the trading volume and bid-ask spread for Genesis Healthcare. Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares at desired prices, potentially leading to significant transaction costs and price volatility. Investors should exercise caution and consider the potential for illiquidity when trading GENN on the OTC market.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Higher price volatility due to lower trading volume.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight and investor protection.
  • Going concern risk due to financial distress.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's management team and corporate governance practices.
  • Review the company's risk factors and legal disclosures.
  • Check for any regulatory actions or investigations.
  • Monitor the company's news and press releases.
  • Consult with a financial advisor before investing.
Señales de legitimidad:
  • Established history of operations in the healthcare sector.
  • Presence of experienced management team.
  • Network of skilled nursing and assisted living facilities.
  • Provision of essential healthcare services.
  • Compliance with regulatory requirements.

Preguntas Comunes Sobre GENN

¿Cuáles son los factores clave para evaluar GENN?

Genesis Healthcare, Inc. (GENN) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Extensive network of facilities.. Riesgo principal a monitorear: Potential: Increasing competition from other healthcare providers.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de GENN?

GENN actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de GENN?

Los precios de GENN se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre GENN?

La cobertura de analistas para GENN incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en GENN?

Las categorías de riesgo para GENN incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increasing competition from other healthcare providers.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de GENN?

La relación P/E para GENN compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está GENN sobrevalorada o infravalorada?

Determinar si Genesis Healthcare, Inc. (GENN) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de GENN?

Genesis Healthcare, Inc. (GENN) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data as of December 31, 2020.
  • OTC market data may be limited and less reliable than exchange-listed stocks.
  • AI analysis pending for GENN.
Fuentes de datos

Popular Stocks